Minimize Uncertainty – Make Informed Decisions – Succeed

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Bristol Myers Squibb's acquisition of Orbital Therapeutics

October 10, 2025reimbursement,Regulatory,Cell Therapy,Autoimmune Disease,biopharma,RNA therapeutics,in vivo CAR-T,Lucid Diligence Brief,payer access,diligenceM&A

Lucid Diligence Brief: Bristol Myers Squibb's acquisition of Orbital…

by Timos Papagatsias

Public_Health

Latest Public Health News - Sept 27th to Oct 10th

October 10, 2025Sugar-sweetened beverages,Artificial sweeteners,Asthma,Public Health News,BioPharma and Tech News,WHO,hypertension,Xenotransplantation,vaping,malaria prevention,MASLD,major depression,Budesonide–formoterol,Salbutamol,Cancer in MillennialsTobacco use,Permethrin

Watch Our Video Summary Capturing Top Public Health News from the Last Two…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Novo Nordisk to acquire Akero Therapeutics for up to $5.2 billion

October 10, 2025EFX,hepatology,FGF21 analogue,metabolic disease,FDA,NASH,biotech M&A,wegovy,liver fibrosis,pharma dealmaking,semaglutide,F2–F3,EMA,compensated cirrhosis,GLP-1,Rezdiffra,Novo Nordisk,resmetirom,Tirzepatide,GIP,MASH,SYNCHRONY Histology,Phase 3,SYNCHRONY Outcomes,accelerated approval,MHRA,MASLD,payer access,Lucid Diligence Brief,prior authorization,Akero Therapeutics,PBM,efruxiferminformulary

Lucid Diligence Brief: Novo Nordisk to acquire Akero Therapeutics for up to…

by Timos Papagatsias

Public_Health

Public Health Weekly News - October 10th 2025

October 10, 2025neuropeptide Y,Y1 receptor,Alzheimer's Disease,ADAMTS2,BioPharma and Tech News,major depression,WHO,histotripsy,Xenotransplantation,ultrasound ablation,Sex Differences,Public Health News,e-cigarettes,vaping,adolescents,malaria prevention,permethrin-treated wraps,MASLD,nonalcoholic fatty liver diseaseinvasive lobular carcinoma,pig liver transplant

Public Health Update: Vaping Surge, Liver Risks, Pain Pathways, and More From…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - October 9th 2025

October 9, 2025Rocket Pharmaceuticals,Cell and Gene Therapy News,takeda,BioPharma and Tech News,CAR T,Friedreich ataxia,JCR Pharmaceuticals,JUST-AAV,GEMMABio,Rare Therapeutics,GM1,Krabbe,MLD,Lexeo TherapeuticsCSL Behring,Hemgenix

Gene & Cell Therapy Update: JCR CNS/Muscle AAV, Lexeo FA Data, RareTx…

by LucidQuest

Cardiovascular

Latest Cardiovascular News - Sept 26th to Oct 9th 2025

October 9, 2025Smart Implant,DNA Surgery,Amgen,Cardiovascular News,BioPharma and Tech News,Novo Nordisk,cardiovascular health,Oral Semaglutide,apixaban,JACARDI,Relief Cardiovascular,CityUHK,Taho Pharmaceuticals,PCSK9 inhibitor,European UnionAir Quality,Nicotine Regulation

Watch Our Video Summary Capturing Top Cardiovascular News from the Last Two…

by LucidQuest

Cardiovascular

Cardiovascular Weekly News - October 9th 2025

October 9, 2025Cordella,Evolocumab,Amgen,Baxdrostat,astrazeneca,Cardiovascular News,BioPharma and Tech News,TAVR,Repatha,Edwards Lifesciences,apixaban,Sapien 3,Pascal,Evoque,Taho Pharmaceuticals,Elixir MedicalLithiX HC-IVL,JenaValve

Cardiovascular Update: Edwards Structural Heart, Repatha VESALIUS-CV,…

by LucidQuest

Rare Disease news

Latest Rare Disease News - Sept 26th to Oct 9th 2025

October 9, 2025LGMDR9,Dyne Therapeutics,gene editing,BioPharma and Tech News,MPS IIIB,Stargardt Disease,JCR Pharmaceuticals,Cure Rare Disease,FKRP,DMD exon 51,Evkeeza,HoFH,GEMMA Biotherapeutics,Fanconi anemia,ABCA4PH1

Watch Our Video Summary Capturing Top Rare Disease News from the Last Two……

by LucidQuest

Vaccines

Vaccines Weekly News - October 9th 2025

October 9, 2025typhoid vaccine,Fast Track designation,Alzheimer's Disease,Vaccine news,Malaria Vaccine,monoclonal antibody,BioPharma and Tech News,mpox,melanoma vaccine,Bharat Biotech,TNBC,breast cancer vaccine,Invivyd,COVID prevention,smallpoxCEPI,amyloid-beta

Vaccine Research Update: COVID Prevention, Malaria Rollout, Cancer Progress,…

by LucidQuest

Rare Disease news

Rare Diseases Weekly News - October 9th 2025

October 9, 2025EPP,PH1,gene editing,Rare Disease News,Duchenne Muscular Dystrophy,BioPharma and Tech News,Stargardt Disease,Rare Therapeutics,Krabbe,MLD,Rocket Pharmaceuticals,GEMMA Biotherapeutics,GM1 gangliosidosis,Fanconi anemia,ABCA4Rett syndrome,AAV optimization

Rare Disease Update: GEMMABio RareTx, AAVantgarde Approvals, Neurotech RPDD,…

by LucidQuest

Respiratory

Respiratory Today—October 9, 2025

October 9, 2025COVID-19 prevention,COPD therapy,BioPharma and Tech News,Respiratory News,Alvotech,omalizumab biosimilar,Leyden Labs,pan-influenza vaccine,EIC Fund,Invest-NL,Savara,molgramostim,aPAP,IMPALA-2,Lyra Therapeuticschronic rhinosinusitis,Invivyd

Respiratory Health Update: PanFlu Funding, COPD Expansion, New IPF…

by LucidQuest

Immunology

Latest Immunology News - Sept 25th to Oct 8th 2025

October 8, 2025PARADIGM,tocilizumab-anoh,endoluminal robotics,IL-6,reimbursement,ESD,biosimilar,Celltrion,Arcutis,Immunology News,BioPharma and Tech News,roflumilast 0.05%,melanoma,pediatric AD,Odevixibat,PDE4,IO Biotech,cylembio,Ipsen,Nobel Prize,EndoQuest Robotics,FOXP3,Bylvay,immune tolerance,PFIC,CARRA,Aera Therapeutics,STOP-JIA,targeted LNP,early biologic,in vivo CAR-T,methotrexateRegulatory T cells,AVTOZMA

Watch Our Video Summary Capturing Top Immunology News from the Last Two Weeks…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.